Vancouver, British Columbia, March 4, 2021 – Global Wellness Strategies Inc. (formerly Redfund Capital Corp.)(CSE: LOAN) (Frankfurt:O3X4) (OTC QB: PNNRF) (“Global” or the “Company”) unveils the first new product for KaleidoUSA; hemp extract infused myco effervescent.
First Infused Myco Product:
KaleidoUSA is proud to introduce their first-ever dissolvable hemp extract infused myco tablets to enter the effervescent category. The tablets dissolve quickly in a glass of water, adding effervescence and flavor, and are an excellent way to supplement a healthy diet with an array of complementary and synergistic ingredients. KaleidoUSA’s new IP formula creates an on-the-go option for myco hemp-derived consumer products that promote optimal wellness. www.kaleidomyco.com
Established Manufacturer Partnership:
KaleidoUSA will manufacture all its products at Intercontinental Hemp LLC. based in Washington State. Intercontinental is optimizing its existing extraction equipment for the functional mushroom products. It has a state hemp processing license and meets FDA food grade and GMP pharma standards, and has the ability to ship nationwide as well as to other countries where hemp extract is approved.
Meris Kott, CEO, Global Wellness Strategies Inc. said “Being a first mover in the myco-dosing space with a new IP effervescent is exciting for KaleidoUSA. Having a strong manufacturing partnership for KaleidoUSA with Intercontinental Hemp is the key to their success. A team member of Global Wellness visited the co-packer facility last week and we are reviewing the materials from the site visit. We look forward to presenting the entire due diligence package before committee shortly and signing a definitive agreement with KaleidoUSA.”
“According to SPINS data on the 52 weeks ending November 29, 2020, “mushrooms (other)” grew in sales by 46% compared to 2019 to reach $14.7 million in sales, making it one of the 25 bestselling ingredients in the natural channel. Within the natural channel’s immune-health category, mushrooms (other)” grew 53.8% to become the top-selling ingredient in the category.” (SPINS LLC is a wellness-focused data company and advocate for the Natural Products Industry)
About KaleidoUSA
KaleidoUSA is the world’s first company combining hemp extract, adaptogens, psilocybin and myco based ingredients to produce world-class, data-driven, science-based wellness products. It is dedicated to driving ground breaking innovations in the production and delivery of myco derived formulations.
About Global Wellness Strategies
Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, hemp and CBD, healthcare- related target companies.
For further information please visit out website : www.globalwellnessstrategies.com Or
Contact Meris Kott CEO 604.484.0355 or
email to [email protected]
Further information about the Company is available on www.SEDAR.com under the Company’s profile.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward- looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
